Exchange: NASDAQ·Updated 03:58 PM EDT
CRIS logo

CRIS Curis Inc

$1.14
$0.01
(0.89%)
Today
EarningsNov 5
Mkt Cap$2.36M
Vol123,673.00

About CRIS

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170 and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.
57

Bullish Sentiment

How do you feel about CRIS?

Advertisement|Remove ads.